RNA-diethylstilbestrol interaction studied by Fourier transform infrared difference spectroscopy.
Diethylstilbestrol (DES), a synthetic estrogen, is known to be a carcinogen in human and in animals. This study was designed to examine the interaction of DES with yeast RNA in aqueous solution at physiological pH with drug/RNA-phosphate (P) molar ratios of 1/80, 1/40, 1/20, 1/10, 1/4, and 1/2. Fourier transform infrared (FTIR) difference spectroscopy was used to determine the drug binding mode, the binding constant, the sequence selectivity, and RNA secondary structure in the RNA.DES complexes. Spectroscopic evidence showed that at low drug concentration (1/80 and 1/40), DES is intercalating through both Gua-Cyt and Ade-Urd base pairs with minor interaction with the backbone PO2 group (external binding). The calculated binding constant of K approximately 8.5 x 10(4) M-1 at a drug concentration of 3.12 x 10(-4) M shows that DES is a weaker intercalator than those of the methylene blue, acridine orange, and ethidium bromide. At high drug content (r > 1/40, where r represents the DES/RNA-phosphate molar ratio), a partial helix destabilization occurs with no alteration of RNA conformation upon drug complexation. However, a comparison with DNA.DES complexes showed that drug intercalation causes major reduction of the B-DNA structure in favor of A-DNA with no participation of the backbone PO2 group in the DES. DNA complexation.
Neault
J F
JF
Department of Chemistry-Biology, University of Québec at Trois-Rivières, C.P. 500 TR, Québec, Canada G9A 5H7.
Tajmir-Riahi
H A
HA
D004247:DNA / Q000378:metabolism; D004054:Diethylstilbestrol / Q000378:metabolism*; D006863:Hydrogen-Ion Concentration; D009690:Nucleic Acid Conformation; D012313:RNA / Q000378:metabolism*; D012996:Solutions; D017550:Spectroscopy, Fourier Transform Infrared; D013059:Spectrum Analysis, Raman
D012996:Solutions; D012313:RNA; D004054:Diethylstilbestrol; D004247:DNA